U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07121842) titled 'Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI' on July 31.
Brief Summary: In this study, the invesigators look at how a new MRI technique (called amide proton transfer weighted (APTw) chemical exchange saturation transfer (CEST)) can improve treatment for brain tumors through early detection of tumor progression after radiotherapy and/or chemotherapy treatment.
An issue with the current treatment for patients with a brain tumor, is the inability to detect tumor progression early. An abnormality is seen on MRI scans taken shortly after treatment with radiotherapy in about 30% of patients.
This abno...